Shares lessons from three states participating in the CDC’s 6|18 Initiative that pursued cross-agency strategies to expand the National Diabetes Prevention Program to prevent and/or delay the onset of type 2 diabetes amid the COVID-19 pandemic.
Highlights 6|18’s role in strengthening partnerships to increase access to and use of evidence-based tobacco cessation services for Medicaid beneficiaries.
Identifies several common approaches that state tobacco control programs may consider when pursuing pharmacotherapy reimbursements in partnership with their Medicaid agencies and quitline service providers.
Describes an innovative health care provider-targeted media campaign conducted by the New York State Department of Health’s Tobacco Control Program.